Advertisement

Topics

Teva Pharmaceutical Industries Limited (TEVA) Cut to "Sell" at Vetr Inc.

01:24 EDT 23 Jun 2017 | Topix

They presently have a $31.05 target price on the stock. Vetr 's target price points to a potential downside of 4.52% from the company's current price.

Original Article: Teva Pharmaceutical Industries Limited (TEVA) Cut to "Sell" at Vetr Inc.

NEXT ARTICLE

More From BioPortfolio on "Teva Pharmaceutical Industries Limited (TEVA) Cut to "Sell" at Vetr Inc."

Advertisement
Quick Search
Advertisement
Advertisement